PETALING JAYA: Maybank IB Research is the second research house over the last five months to upgrade its recommendation on KPJ Healthcare Bhd to “buy”, as it believes the stock’s selling is overdone and new value is expected to emerge.
The research house has forecast KPJ to record stronger results in the third quarter of financial year 2019 (3Q19), exceeding the RM43.4mil core net profit registered in 2Q19.
Already a subscriber? Log in.
Subscribe to win RM50 Touch 'n Go e-Voucher! More Info
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!